EA201791299A1 - Микроинкапсулированные композиции каннабиноидов - Google Patents
Микроинкапсулированные композиции каннабиноидовInfo
- Publication number
- EA201791299A1 EA201791299A1 EA201791299A EA201791299A EA201791299A1 EA 201791299 A1 EA201791299 A1 EA 201791299A1 EA 201791299 A EA201791299 A EA 201791299A EA 201791299 A EA201791299 A EA 201791299A EA 201791299 A1 EA201791299 A1 EA 201791299A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- microincapsulated
- cannabinoids
- microencapsulated
- encapsulated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229930003827 cannabinoid Natural products 0.000 title abstract 2
- 239000003557 cannabinoid Substances 0.000 title abstract 2
- 229940065144 cannabinoids Drugs 0.000 title 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/001—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
- A23G9/52—Liquid products; Solid products in the form of powders, flakes or granules for making liquid products ; Finished or semi-finished solid products, frozen granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Настоящее изобретение относится к композициям каннабиноидов. Эти композиции могут являться инкапсулированными (например, микроинкапсулированными). В частности, эти композиции могут быть введены субъекту, например, через оральное употребление или местное лечение.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462091445P | 2014-12-12 | 2014-12-12 | |
US201562128761P | 2015-03-05 | 2015-03-05 | |
PCT/US2015/065268 WO2016094810A2 (en) | 2014-12-12 | 2015-12-11 | Microencapsulated cannabinoid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791299A1 true EA201791299A1 (ru) | 2017-12-29 |
Family
ID=56108379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791299A EA201791299A1 (ru) | 2014-12-12 | 2015-12-11 | Микроинкапсулированные композиции каннабиноидов |
Country Status (12)
Country | Link |
---|---|
US (2) | US10080736B2 (ru) |
EP (1) | EP3229789A4 (ru) |
JP (3) | JP2018505912A (ru) |
CN (1) | CN107205981A (ru) |
AU (2) | AU2015360349B2 (ru) |
BR (1) | BR112017012434A2 (ru) |
CA (1) | CA2970651C (ru) |
EA (1) | EA201791299A1 (ru) |
HK (1) | HK1244710A1 (ru) |
IL (2) | IL292818A (ru) |
MX (2) | MX2021010033A (ru) |
WO (1) | WO2016094810A2 (ru) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10350165B2 (en) | 2014-12-12 | 2019-07-16 | Ojai Energetics Pbc | Methods and systems for forming stable droplets |
US10369178B2 (en) * | 2016-03-06 | 2019-08-06 | Resurgent Pharmaceuticals, Inc. | Tobacco products with cannabinoid additives and methods for reducing the harm associated with tobacco use |
US20180206518A1 (en) | 2016-04-15 | 2018-07-26 | Ronald Silver | Method of making cannabis oil hydrophilic using emulsifiers and related cannabinoid compositions |
CA3021093A1 (en) | 2016-04-15 | 2017-10-19 | Sre Wellness, Inc. | Cannabis infused sweeteners and other compositions |
WO2017218853A1 (en) * | 2016-06-15 | 2017-12-21 | Ojai Energetics Pbc | Methods and compositions for reducing oxidative stress |
WO2017218846A1 (en) * | 2016-06-15 | 2017-12-21 | Ojai Energetics Pbc | Methods and compositions for potentiating stem cell therapies |
JP2019523283A (ja) | 2016-08-03 | 2019-08-22 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
PE20200677A1 (es) * | 2016-08-03 | 2020-06-11 | Zelda Therapeutics Operations Pty Ltd | Composicion de cannabis |
US10525093B2 (en) * | 2016-11-14 | 2020-01-07 | Farm To Farma, Inc. | Cannabinoid formulations and method of making the same |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US20190321355A1 (en) * | 2016-12-15 | 2019-10-24 | Sharon Anavi-Goffer | Treatment of mental, movement and behavioral disorders |
EP3595646A4 (en) * | 2017-03-18 | 2021-01-13 | McGarrah, Steven, M. | PET FOOD WITH CANNABIDIOLIC ACID |
CA3057677A1 (en) * | 2017-03-27 | 2018-10-04 | Patagonia Pharmaceuticals, Llc | Topical compositions and methods of treatment |
CA3064563A1 (en) * | 2017-05-22 | 2018-11-29 | Gbs Global Biopharma, Inc. | Myrcene-containing complex mixtures targeting trpv1 |
WO2018213932A1 (en) * | 2017-05-26 | 2018-11-29 | Altum Pharmaceuticals Inc. | Biphasix cannabinoid delivery |
WO2018228616A1 (en) * | 2017-06-16 | 2018-12-20 | Bednarik Frantisek | A composite mixture comprising cannabis sativa |
BR112019026635A2 (pt) * | 2017-06-30 | 2020-06-30 | Creso Pharma Switzerland Gmbh | composição veterinária ou suplemento de dieta |
WO2019014631A1 (en) * | 2017-07-14 | 2019-01-17 | 5071, Inc. | CANNABINOID COMPOSITIONS AND PREPARATION METHODS THEREFOR |
CO2017007962A1 (es) * | 2017-08-04 | 2018-04-19 | Alsec Alimentos Secos S A S | Nanoparticulas oleosas de cannabis microencapsuladas en polvo |
WO2019049142A1 (en) * | 2017-09-08 | 2019-03-14 | Scicann Therapeutics Inc. | COMPOSITIONS COMPRISING CANNABINOID AND SPILANTHOL |
CN107903655A (zh) * | 2017-10-18 | 2018-04-13 | 湖北科技学院 | 一种从桂花果皮中提取黑色素的方法及其应用 |
EP3703672A4 (en) * | 2017-10-30 | 2021-12-01 | Endocanna Health, Inc. | CANNABINOID FORMULATIONS |
US20200330378A1 (en) * | 2018-01-03 | 2020-10-22 | Icdpharma Ltd. | Taste-enhanced cannabinoid submicron emulsion syrup compositions |
WO2019136351A1 (en) * | 2018-01-05 | 2019-07-11 | Altus Labs, Llc | Personal care compositions |
CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
MX2020009390A (es) * | 2018-03-14 | 2021-01-15 | Poviva Corp | Suministro transdermico y/o dermico de agentes activos lipofilicos. |
CA3096842A1 (en) | 2018-04-09 | 2019-10-17 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
GB201806953D0 (en) * | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
CA3103504A1 (en) * | 2018-06-15 | 2019-12-19 | CannPal Animal Therapeutics Limited | Cannabinoid composition and methods of treatment using the same |
GB2576636B (en) * | 2018-08-06 | 2022-03-30 | Ubeauty Global | A tanning composition |
CN109045045B (zh) * | 2018-08-14 | 2020-10-09 | 淮南师范学院 | 一种治疗心脑血管疾病的中药活性成分组合物 |
US11517685B2 (en) | 2019-01-18 | 2022-12-06 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
US11690963B2 (en) | 2018-08-22 | 2023-07-04 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
US20210186870A1 (en) * | 2018-08-27 | 2021-06-24 | Emerald Health Therapeutics Canada Inc. | Improved cannabinoid bioavailability |
US10966924B2 (en) | 2018-09-04 | 2021-04-06 | Babak Ghalili | Veterinary cannabinoid, menthol and anesthetic compositions and methods |
US10695301B2 (en) | 2018-09-04 | 2020-06-30 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
US11185526B2 (en) | 2018-09-04 | 2021-11-30 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
US11147775B2 (en) | 2018-09-04 | 2021-10-19 | Babak Ghalili | Cannabinoid and menthol gel compositions, patches and methods |
IL261774B (en) * | 2018-09-13 | 2020-04-30 | Unv Medicine Ltd | Compositions for treating dermatological conditions |
MX2021003832A (es) * | 2018-10-04 | 2021-09-08 | India Globalization Capital Inc | Metodo y composicion para aliviar la fatiga y restaurar la energia. |
WO2020081874A1 (en) * | 2018-10-18 | 2020-04-23 | Respira Technologies, Inc. | Electronic device for producing an aerosol for inhalation by a person |
CN111183989A (zh) * | 2018-11-14 | 2020-05-22 | 北京中以新农高科商务咨询有限公司 | 包含胶囊化挥发性精油和溶解在其中的聚合物的农用制剂 |
GB2579179A (en) * | 2018-11-21 | 2020-06-17 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
US20200188301A1 (en) | 2018-12-14 | 2020-06-18 | NuVessl, Inc. | Method for Enhancing Passenger Molecule Loading |
GB2598458A (en) * | 2018-12-18 | 2022-03-02 | Ojai Energetics Pbc | Cannabinoid compositions for virtual and augmented reality experiences |
US20220054380A1 (en) * | 2018-12-25 | 2022-02-24 | Epm (Ip), Inc. | Cannabidioloic acid esters for cosmetic or edible compositions |
EP3902553A4 (en) * | 2018-12-27 | 2022-10-05 | Buzzelet Development And Technologies Ltd | ENRICHED CANNABINOID COMPOSITION IN HERBAL PREPARATION AND METHOD OF TREATMENT |
AU2019413789A1 (en) * | 2018-12-29 | 2021-08-12 | Buzzelet Development And Technologies Ltd. | Isolated or synthetic cannabinoid compositions with selected terpene blend and methods of use thereof |
EP3911148A4 (en) * | 2019-01-17 | 2022-10-12 | Synthonics, Inc. | SOLID MICELLAR COMPOSITIONS OF CANNABINOID ACIDS |
EP3917505A4 (en) * | 2019-01-29 | 2022-11-02 | Buzzelet Development And Technologies Ltd | TERPENE ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT FOR TREATING CONDITIONS AND/OR SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER |
WO2020176547A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
AU2020244352A1 (en) * | 2019-03-21 | 2021-11-11 | Alvit Lcs Pharma Ltd. | Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases |
IL287654B (en) * | 2019-05-06 | 2022-07-01 | Atomic Health Inc | Systems and methods for producing cannabis foods and edible products obtained as a result |
WO2020230071A1 (en) * | 2019-05-16 | 2020-11-19 | Buzzelet Development And Technologies Ltd. | Local anesthetic comprising a trp channel modulator |
CN110025595A (zh) * | 2019-05-27 | 2019-07-19 | 西宝生物科技(上海)股份有限公司 | 一种高稳定可水溶性工业大麻cbd微囊的制备方法 |
US20200397693A1 (en) * | 2019-06-24 | 2020-12-24 | Hempvana, Llc | Compositions comprising cannabis sativa oil and uses thereof |
US11622956B1 (en) | 2019-06-26 | 2023-04-11 | RCR BioPharma | Compound and method for treating diseases and disorders |
US10588871B1 (en) | 2019-06-28 | 2020-03-17 | Nexzol Pharma, Inc. | Transdermal formulation for the treatment of pain and/or inflammation |
AU2019454044A1 (en) * | 2019-06-28 | 2022-01-20 | Nexzol Pharma, Inc. | Transdermal formulation for the treatment of pain and/or inflammation |
CA3145830A1 (en) * | 2019-07-02 | 2021-01-07 | Ellevet Sciences | Hemp extract for treatment of pain, cancer and epilepsy in animals |
US20210023023A1 (en) * | 2019-07-25 | 2021-01-28 | Vasayo, Llc | Liposomal nutraceutical compositions and methods of making the same |
US20210023005A1 (en) | 2019-07-26 | 2021-01-28 | Landsteiner Scientific S.A. De C.V. | Cannabinoid-containing compositions in the form of spheres or sphere-like particles, methods for their preparation, and therapeutic applications |
WO2021026366A1 (en) * | 2019-08-06 | 2021-02-11 | Nuka Enterprises | Consumable compositions and methods of producing the same |
CA3148970A1 (en) * | 2019-08-26 | 2021-03-04 | Gianna Marie FILIPETTO | Method and apparatus for the infusion of cannabinoids into a shelf-stable food composition |
US20210169820A1 (en) | 2019-09-12 | 2021-06-10 | Nulixir Inc. | Controlled release concentrate and suspensions including the same |
US11542243B1 (en) | 2019-09-26 | 2023-01-03 | FusionFarms, LLC | Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization |
EP4081208A4 (en) * | 2019-12-28 | 2024-01-03 | Buzzelet Development And Technologies Ltd | LIQUID COMPOSITIONS COMPRISING TERPENES AND CANNABINOIDS |
CA3168493A1 (en) * | 2020-02-20 | 2021-08-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Use of castalagin or analogs thereof for anti-cancer efficacy and to increase the response to immune checkpoint inhibitors |
WO2021178465A1 (en) * | 2020-03-02 | 2021-09-10 | Clear Lake Research, Llc | Buccal and enteric delivery of fatty acids with oral hygiene practices |
WO2021178579A1 (en) * | 2020-03-03 | 2021-09-10 | Alte Verde Llc | Cannabis treatment of insomnia, pain, and skin conditions |
WO2021202413A1 (en) * | 2020-03-30 | 2021-10-07 | Ojai Energetics Pbc | Systems, methods, and compositions for infections |
WO2021211915A1 (en) * | 2020-04-17 | 2021-10-21 | University Of Connecticut | Polycannabinoids, compounds, compositions and methods of use |
WO2021216640A1 (en) * | 2020-04-21 | 2021-10-28 | Coolhouse Sourcing Llc | Composition, article and method for affecting a mammal |
US20230404944A1 (en) * | 2020-11-06 | 2023-12-21 | Zelira Therapeutics Operations Pty Ltd | Cannabinoid encapsulation technology |
CN112472661A (zh) * | 2020-12-11 | 2021-03-12 | 云南苏旺润生物医药有限公司 | 一种大麻二酚按摩油组合物及其制备方法和应用 |
US20220218649A1 (en) * | 2021-01-07 | 2022-07-14 | Mai Nguyen | Composition for treating opioid withdrawal and method of manufacture |
KR102278512B1 (ko) | 2021-01-19 | 2021-07-20 | 정진욱 | 광화학 반응시켜 카나비디올 및 풀빅산을 함유하며, 상기 카나비디올 및 풀빅산 성분이 식용 곤충, 파충류, 연체류, 및 가축류로의 천이 가능한 사료 조성물 및 이의 제조방법 |
US20220266206A1 (en) * | 2021-02-19 | 2022-08-25 | Gaia Botanicals Llc Dba Bluebird Botanicals | Formulation and process for manufacturing a heat stable oil-in-water emulsion for cannabis beverages in plastic bottles |
IT202100006893A1 (it) * | 2021-03-22 | 2022-09-22 | Kolinpharma S P A | Una formulazione in forma di microgranuli comprendente un estratto o molecola di origine vegetale avente effetti gastrolesivi o instabilità a ph acido, e una matrice gastroresistente |
US11844361B2 (en) | 2021-04-08 | 2023-12-19 | Wiparo Biomed Limited | Stem cell boosting chocolate composition |
CN113332278A (zh) * | 2021-06-03 | 2021-09-03 | 威海华新药业集团有限公司 | 一种靛红和二氢大麻酚复合物及其医疗用途 |
WO2022269616A1 (en) * | 2021-06-24 | 2022-12-29 | Ramot At Tel-Aviv University Ltd. | Combination compositions for the treatment of pathogen infections and associated complications |
WO2023278768A1 (en) * | 2021-06-30 | 2023-01-05 | Demetrix, Inc. | Alleviation of itching sensations using cannabinoid compounds |
EP4134073A1 (en) | 2021-08-11 | 2023-02-15 | HM HerbaMedica GmbH | Pharmaceutical compositions comprising dendritic nanocarriers and cannabis active agents |
CA3130284A1 (en) * | 2021-09-09 | 2023-03-09 | Faezeh Dousty | Cannabinoid-humic substances composition and method of making the same |
WO2023183618A1 (en) * | 2022-03-25 | 2023-09-28 | Ojai Energetics Pbc | Psychedelic compositions and methods for forming the same |
WO2023205385A1 (en) | 2022-04-22 | 2023-10-26 | Qnovia, Inc. | Electronic devices for aerosolizing and inhaling liquid |
WO2023245107A1 (en) * | 2022-06-15 | 2023-12-21 | Phyto Tech Corp. | Microencapsulation of cannabidiol or its mixture with nicotine for oral and topical administration |
CN115068441B (zh) * | 2022-06-30 | 2023-04-14 | 东北农业大学 | 一种水溶性大麻二酚微胶囊及其制备方法 |
CN115364050B (zh) * | 2022-08-02 | 2023-07-18 | 无锡诺平医药科技有限公司 | H2cbd乳液、制备方法及其药物应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3456049A (en) | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
JPS5948414A (ja) * | 1982-09-10 | 1984-03-19 | Asahi Denka Kogyo Kk | ビタミンeの水溶性製剤 |
JPS6051104A (ja) * | 1983-08-30 | 1985-03-22 | Ajinomoto Co Inc | ビタミンe含有水性液剤 |
JPS6398369A (ja) * | 1986-10-14 | 1988-04-28 | Maruzen Kasei Kk | 飲料用クラウデイ− |
US4888194A (en) * | 1986-12-10 | 1989-12-19 | Borden, Inc. | Shelf-stable aseptic dairy product |
US5674522A (en) * | 1993-10-07 | 1997-10-07 | Mcneil-Ppc, Inc. | Beverage concentrate for drug delivery |
US5885594A (en) * | 1997-03-27 | 1999-03-23 | The Procter & Gamble Company | Oral compositions having enhanced mouth-feel |
WO2002070506A2 (en) | 2001-03-07 | 2002-09-12 | Websar Innovations Inc. | Conversion of cbd to δ8-thc and δ9-thc |
DE10258867A1 (de) * | 2002-12-17 | 2004-07-08 | Bayer Cropscience Gmbh | Mikroemulsionskonzentrate |
ES2235642B2 (es) * | 2003-12-18 | 2006-03-01 | Gat Formulation Gmbh | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. |
GB0409104D0 (en) * | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
AU2005265031A1 (en) | 2004-06-17 | 2006-01-26 | Forest Laboratories, Inc. | Modified release formulation of memantine |
GB0504950D0 (en) * | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
US8017152B2 (en) * | 2005-05-27 | 2011-09-13 | Stratosphere Pharma Ab | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
CA2607600A1 (en) | 2005-06-16 | 2006-12-28 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
US20080242741A1 (en) * | 2007-03-30 | 2008-10-02 | Wayne Jeffrey Perry | Intranasal drug delivery system |
US20090110674A1 (en) * | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
WO2011044523A2 (en) * | 2009-10-09 | 2011-04-14 | Atheronova Operations, Inc. | Compositions and methods for treating obesity |
EP2563164B1 (en) * | 2010-03-23 | 2016-06-29 | Virun, Inc. | Nanoemulsion including sucrose fatty acid ester |
US20120043242A1 (en) | 2010-08-19 | 2012-02-23 | Andrew David Hospodor | Medicinal cannabis fatty foodstuff |
US20120231083A1 (en) * | 2010-11-18 | 2012-09-13 | The Board Of Trustees Of The University Of Illinois | Sustained release cannabinoid medicaments |
WO2012075575A1 (en) * | 2010-12-10 | 2012-06-14 | The Governors Of The University Of Alberta | Barley protein microcapsules |
WO2013009928A1 (en) * | 2011-07-11 | 2013-01-17 | Organic Medical Research | Cannabinoid formulations |
GB2495118B (en) * | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
ES2739194T3 (es) * | 2012-01-19 | 2020-01-29 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Formulación y método para aumentar la biodisponibilidad oral de fármacos |
EP2934512B1 (en) * | 2012-12-18 | 2021-11-24 | Kotzker Consulting LLC | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
CA3012383C (en) | 2013-02-28 | 2021-03-02 | Teewinot Technologies Limited | Biosynthesis of cannabinoids |
RU2016129536A (ru) * | 2013-10-31 | 2018-01-31 | Фулл Спектрум Лабораториз, Лтд. | Препараты на основе терпенов и каннабиноидов |
US20160089320A1 (en) | 2014-09-29 | 2016-03-31 | Barrie Tan | Non-Synthetic Emulsion-Based Lipid Formulations and Methods of Use |
-
2015
- 2015-12-11 BR BR112017012434A patent/BR112017012434A2/pt active Search and Examination
- 2015-12-11 AU AU2015360349A patent/AU2015360349B2/en active Active
- 2015-12-11 EP EP15867877.1A patent/EP3229789A4/en active Pending
- 2015-12-11 IL IL292818A patent/IL292818A/en unknown
- 2015-12-11 EA EA201791299A patent/EA201791299A1/ru unknown
- 2015-12-11 MX MX2021010033A patent/MX2021010033A/es unknown
- 2015-12-11 IL IL252881A patent/IL252881B/en unknown
- 2015-12-11 CN CN201580076119.XA patent/CN107205981A/zh active Pending
- 2015-12-11 MX MX2017007550A patent/MX2017007550A/es unknown
- 2015-12-11 WO PCT/US2015/065268 patent/WO2016094810A2/en active Application Filing
- 2015-12-11 JP JP2017550090A patent/JP2018505912A/ja active Pending
- 2015-12-11 CA CA2970651A patent/CA2970651C/en active Active
-
2017
- 2017-03-07 US US15/452,530 patent/US10080736B2/en active Active
-
2018
- 2018-03-30 HK HK18104360.4A patent/HK1244710A1/zh unknown
- 2018-08-08 US US16/058,978 patent/US20180344686A1/en not_active Abandoned
-
2021
- 2021-01-04 AU AU2021200019A patent/AU2021200019B2/en active Active
- 2021-11-12 JP JP2021184612A patent/JP2022023230A/ja not_active Withdrawn
-
2023
- 2023-11-30 JP JP2023202666A patent/JP2024015115A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1244710A1 (zh) | 2018-08-17 |
JP2022023230A (ja) | 2022-02-07 |
US20170172977A1 (en) | 2017-06-22 |
MX2021010033A (es) | 2022-08-25 |
CN107205981A (zh) | 2017-09-26 |
CA2970651C (en) | 2020-09-29 |
AU2021200019B2 (en) | 2022-06-02 |
MX2017007550A (es) | 2018-05-04 |
WO2016094810A3 (en) | 2016-10-13 |
US10080736B2 (en) | 2018-09-25 |
AU2015360349A1 (en) | 2017-07-06 |
US20180344686A1 (en) | 2018-12-06 |
EP3229789A2 (en) | 2017-10-18 |
AU2021200019A1 (en) | 2021-03-18 |
CA2970651A1 (en) | 2016-06-16 |
IL252881B (en) | 2022-06-01 |
IL292818A (en) | 2022-07-01 |
JP2024015115A (ja) | 2024-02-01 |
AU2015360349B2 (en) | 2020-10-08 |
IL252881A0 (en) | 2017-08-31 |
EP3229789A4 (en) | 2018-08-08 |
BR112017012434A2 (pt) | 2018-02-20 |
WO2016094810A2 (en) | 2016-06-16 |
JP2018505912A (ja) | 2018-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791299A1 (ru) | Микроинкапсулированные композиции каннабиноидов | |
CY1122796T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων | |
EA201890204A1 (ru) | Антибактериальные соединения | |
UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
DK3258942T3 (da) | Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol | |
MY165124A (en) | Semifluorinated alkane compositions | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
DK3359142T3 (da) | Medicinsk tyggegummi omfattende cannabinoid | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
BR112016002387A2 (pt) | composições tópicas e métodos de uso das mesmas | |
MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
EA201792612A1 (ru) | 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot | |
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
EA201791174A1 (ru) | Антимикотическое соединение | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
PH12017500348B1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
ECSP16096831A (es) | Derivados de naftiridinadiona | |
MX2015016603A (es) | Composiciones de corticosteroides. | |
MX2016009696A (es) | Formulaciones de antibióticos tópicas.. | |
MX2018011982A (es) | Dispositivo de calentamiento de preparaciones topicas. | |
EA201690709A1 (ru) | Применение одипарцила в лечении мукополисахаридоза |